Details for Patent: 8,039,435
✉ Email this page to a colleague
Which drugs does patent 8,039,435 protect, and when does it expire?
Patent 8,039,435 protects IMCIVREE and is included in one NDA.
This patent has sixty-three patent family members in twenty countries.
Summary for Patent: 8,039,435
| Title: | Melanocortin receptor ligands |
| Abstract: | The present invention is directed to compounds according to formula, (R.sup.2R.sup.3)-A.sup.1-c(A.sup.2-A.sup.3-A.sup.4-A.sup.5-A.sup.6-A.sup.- 7-A.sup.8-A.sup.9)-A.sup.10-R.sup.1, and pharmaceutically-acceptable salts thereof that act as ligands for one or more of the melanocortin receptors, to methods of using such compounds to treat mammals and to pharmaceutical compositions comprising said compounds. |
| Inventor(s): | Dong; Zheng Xin (Holliston, MA), Moreau; Jacques-Pierre (Upton, MA) |
| Assignee: | Ipsen Pharma S.A.S. (Boulogne, FR) |
| Application Number: | 11/988,533 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 8,039,435
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rhythm | IMCIVREE | setmelanotide acetate | SOLUTION;SUBCUTANEOUS | 213793-001 | Nov 25, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,039,435
| PCT Information | |||
| PCT Filed | July 10, 2006 | PCT Application Number: | PCT/US2006/026586 |
| PCT Publication Date: | January 18, 2007 | PCT Publication Number: | WO2007/008704 |
International Family Members for US Patent 8,039,435
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2236151 | ⤷ Sign Up | 301150 | Netherlands | ⤷ Sign Up |
| European Patent Office | 2236151 | ⤷ Sign Up | CA 2021 00053 | Denmark | ⤷ Sign Up |
| European Patent Office | 2236151 | ⤷ Sign Up | 2021C/557 | Belgium | ⤷ Sign Up |
| European Patent Office | 2236151 | ⤷ Sign Up | 122021000084 | Germany | ⤷ Sign Up |
| European Patent Office | 2236151 | ⤷ Sign Up | CR 2021 00053 | Denmark | ⤷ Sign Up |
| European Patent Office | 2236151 | ⤷ Sign Up | 52/2021 | Austria | ⤷ Sign Up |
| European Patent Office | 2236151 | ⤷ Sign Up | 21C1060 | France | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
